JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. (BKK:JSP)
Thailand
· Delayed Price · Currency is THB 1.820
+0.010 (0.55%)
May 9, 2025, 12:02 PM ICT
BKK:JSP Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Operating Revenue | 824.49 | 575.58 | 458.07 | 422.34 | 455.64 | Upgrade
|
| Other Revenue | 21.45 | 18.78 | 8.73 | 6.78 | 7.1 | Upgrade
|
| Revenue | 845.93 | 594.36 | 466.8 | 429.13 | 462.74 | Upgrade
|
| Revenue Growth (YoY) | 42.33% | 27.32% | 8.78% | -7.27% | 25.29% | Upgrade
|
| Cost of Revenue | 519.49 | 432.06 | 313.11 | 277.97 | 310.02 | Upgrade
|
| Gross Profit | 326.44 | 162.3 | 153.69 | 151.15 | 152.73 | Upgrade
|
| Selling, General & Admin | 221.41 | 163.37 | 154.6 | 102.86 | 97.49 | Upgrade
|
| Operating Expenses | 224.09 | 162.71 | 154.77 | 102.86 | 99.61 | Upgrade
|
| Operating Income | 102.35 | -0.41 | -1.07 | 48.3 | 53.12 | Upgrade
|
| Interest Expense | -16.57 | -13 | -9.19 | -10.4 | -11.44 | Upgrade
|
| Earnings From Equity Investments | -3.1 | 0.58 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -0.47 | - | Upgrade
|
| EBT Excluding Unusual Items | 82.69 | -12.83 | -10.26 | 37.43 | 41.68 | Upgrade
|
| Gain (Loss) on Sale of Investments | -115.99 | 39.91 | 8.89 | - | - | Upgrade
|
| Asset Writedown | - | 9.4 | - | - | -2 | Upgrade
|
| Other Unusual Items | - | -31.04 | -14.42 | - | - | Upgrade
|
| Pretax Income | -33.3 | 5.44 | -15.79 | 37.43 | 39.68 | Upgrade
|
| Income Tax Expense | -0.13 | 9.1 | 1.7 | 7.74 | 8.59 | Upgrade
|
| Earnings From Continuing Operations | -33.17 | -3.66 | -17.48 | 29.69 | 31.08 | Upgrade
|
| Minority Interest in Earnings | 37.7 | 1.94 | 0 | - | - | Upgrade
|
| Net Income | 4.52 | -1.72 | -17.48 | 29.69 | 31.08 | Upgrade
|
| Net Income to Common | 4.52 | -1.72 | -17.48 | 29.69 | 31.08 | Upgrade
|
| Net Income Growth | - | - | - | -4.48% | 31.91% | Upgrade
|
| Shares Outstanding (Basic) | 475 | 469 | 455 | 360 | 335 | Upgrade
|
| Shares Outstanding (Diluted) | 475 | 469 | 480 | 360 | 335 | Upgrade
|
| Shares Change (YoY) | 1.16% | -2.35% | 33.27% | 7.51% | 16.05% | Upgrade
|
| EPS (Basic) | 0.01 | -0.00 | -0.04 | 0.08 | 0.09 | Upgrade
|
| EPS (Diluted) | 0.01 | -0.00 | -0.04 | 0.08 | 0.09 | Upgrade
|
| EPS Growth | - | - | - | -13.70% | 13.66% | Upgrade
|
| Free Cash Flow | 75.69 | -132.55 | -285.89 | 15.17 | 38.84 | Upgrade
|
| Free Cash Flow Per Share | 0.16 | -0.28 | -0.59 | 0.04 | 0.12 | Upgrade
|
| Dividend Per Share | - | - | - | 0.013 | - | Upgrade
|
| Gross Margin | 38.59% | 27.31% | 32.92% | 35.22% | 33.01% | Upgrade
|
| Operating Margin | 12.10% | -0.07% | -0.23% | 11.25% | 11.48% | Upgrade
|
| Profit Margin | 0.53% | -0.29% | -3.74% | 6.92% | 6.72% | Upgrade
|
| Free Cash Flow Margin | 8.95% | -22.30% | -61.25% | 3.54% | 8.39% | Upgrade
|
| EBITDA | 147.38 | 34.1 | 16.25 | 62.89 | 67.91 | Upgrade
|
| EBITDA Margin | 17.42% | 5.74% | 3.48% | 14.66% | 14.67% | Upgrade
|
| D&A For EBITDA | 45.03 | 34.51 | 17.33 | 14.59 | 14.79 | Upgrade
|
| EBIT | 102.35 | -0.41 | -1.07 | 48.3 | 53.12 | Upgrade
|
| EBIT Margin | 12.10% | -0.07% | -0.23% | 11.25% | 11.48% | Upgrade
|
| Effective Tax Rate | - | 167.14% | - | 20.68% | 21.66% | Upgrade
|
| Revenue as Reported | 845.93 | 594.36 | 466.8 | 429.13 | 462.74 | Upgrade
|
| Advertising Expenses | 43.02 | 7.26 | 22.62 | 17.52 | 15.95 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.